The NHS (National Health Service) urges anyone taking digoxin, a common heart medication, to watch for key side effects-and report them fast. Although this medication is used by patients with ...

People prescribed digoxin are being urged by the NHS to speak to their doctor if they experience two common side effects. Digoxin is a cardiac gylocoside medicine that is regulary prescribed to reat a ...

A doctor has claimed that some people may need to give up their favourite sweet treat if they have been prescribed a certain type of medication. People who ignore the warning risk putting themselves ...

A doctor has warned that certain people might need to give up their favourite kind of sweet if they have been told to take a particular form of medication for their heart. Those who ignore this advice ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

The Injective ecosystem is seeing a surge in on-chain activity even as its native token struggles to keep pace. Total value locked (TVL) on Injective has jumped about 14% in the past 24 hours, ...

Pineapple Financial Inc. (NYSE American: PAPL), a Toronto, Ontario-based fintech company, announced the official commencement of its $100 million Injective (INJ) digital asset treasury (DAT) strategy ...

Fox News host Brian Kilmeade called for executing homeless individuals with mental health issues during a September 10 episode of Fox & Friends, suggesting "involuntary lethal injection" as a solution ...

MADRID -- Digitoxin added to guideline-directed medical therapy improved outcomes among patients with heart failure and reduced ejection fraction (HFrEF), the DIGIT-HF trial showed. The cardiac ...

MADRID, Spain—Adding digitoxin, a cardiac glycoside, to contemporary guideline-directed medical therapy (GDMT) improves clinical outcomes in patients who have heart failure with reduced ejection ...

The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...